`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE EASTERN DISTRICT OF VIRGINIA
`ALEXANDRIA DIVISION
`
`
`
`v.
`
`RAI STRATEGIC HOLDINGS, INC. and
`R.J. REYNOLDS VAPOR COMPANY,
`
`Plaintiffs and Counterclaim Defendants,
`
`
`
`ALTRIA CLIENT SERVICES LLC; Philip
`Morris USA INC.; and Philip Morris
`PRODUCTS S.A.,
`
`Defendants and Counterclaim Plaintiffs.
`
`Case No. 1:20-cv-00393-LMB-TCB
`
`
`REYNOLDS’S OBJECTIONS TO THE COURT’S PROPOSED FINAL JURY
`INSTRUCTIONS AND VERDICT FORM
`
`Defendant Reynolds respectfully submits the following objections and suggested revisions
`
`to the Court’s proposed final jury instructions (attached as Exhibit 1) and verdict form (attached
`
`as Exhibit 2). Reynolds preserves its objections (see Dkt. 1315) to the parties’ Joint Proposed
`
`Final Jury Instructions (Dkt. 1204-1) and to Philip Morris’s additional proposed instructions (Dkt.
`
`1314) to the extent they are not reflected in the Court’s proposed instructions.
`
`I.
`
`DOCTRINE OF EQUIVALENTS
`
`For the reasons that follow, the proposed instructions and verdict form questions on
`
`doctrine of equivalents are unnecessary (in the case of the ’265 patent) or legally unsupportable
`
`(in the case of the ’911 patent).
`
`A.
`
`The ’265 Patent
`
`At trial, Philip Morris’s expert on the ’265 patent, Dr. Walbrink, offered a doctrine of
`
`equivalents opinion on only one claim term—“vaporizer membrane.” See June 9, 2022 (AM) Trial
`
`1
`
`
`
`Case 1:20-cv-00393-LMB-TCB Document 1353 Filed 06/14/22 Page 2 of 8 PageID# 33821
`
`Tr. 16–17 (“I find it does include a vaporizer membrane. And even if you weren’t to find it literally
`
`included in there, it also meets the requirements underneath an analysis called the doctrine of
`
`equivalents.”). To streamline the issues for the jury, Reynolds proposes the following stipulation
`
`be read to the jury, contingent on the Court’s removing the doctrine of equivalents question from
`
`the verdict form (Ex. 2, Section I, Question 2):
`
`R.J. Reynolds Vapor Company stipulates that VUSE Alto contains a vaporizer
`membrane as disclosed in Claim 1 of the ’265 patent (PX-002, column 9, lines 42,
`47–48).
`
`With this stipulation, the doctrine of equivalents is no longer relevant to Philip Morris’s
`
`
`
`claim of infringement of the ’265 patent, and the question on this theory of infringement should
`
`be removed from the Court’s verdict form.
`
`B.
`
`The ’911 Patent
`
`Similarly, Philip Morris’s expert on the ’911 patent, Dr. Abraham, offered a doctrine of
`
`equivalents opinion on only one claim term, “cavity,” for the Alto product. See June 8, 2022 (PM)
`
`Trial Tr. 74 (“I think the Alto literally does have the claimed cavity. As I’ve shown from the
`
`documentation, the engineering CAD drawings, and my own investigation, but if it’s decided that
`
`they don’t literally have the cavity, they would also infringe under something called the doctrine
`
`of equivalents ….”). However, Dr. Abraham offered only a literal infringement opinion on the
`
`claim term, “blind hole”:
`
`Q. Let’s turn, then, to that fifth part of Claim 1. What did you find for Alto, Dr.
`Abraham?
`
`A. In my investigation I found that the Alto had the fifth part of the claim as well.
`
`Q. Okay. Let’s go to the next demonstrative, 65. Tell the jury how you know that.
`
`A. On the screen you see photograph PX 38 at page 34, that’s a photograph that I
`took, and I’ve got a white box around an area that I want to draw your attention
`to. On the right-hand side is an image from the CAD file, PX 265A, and I found
`that their device has a cavity in a wall of the aerosol-forming chamber with an
`
`2
`
`
`
`Case 1:20-cv-00393-LMB-TCB Document 1353 Filed 06/14/22 Page 3 of 8 PageID# 33822
`
`open end and a closed end and a longitudinal direction, and I also found it’s a
`blind hole because you can’t see the cavity if you’re from the perspective of the
`red eyeball.
`
`Q. And is that that same “blind hole” term, the one you referenced earlier with
`that passage from the patent?
`
`A. Yes, it is.
`
`Q. Let’s go to the next demonstrative, Dr. Abraham, Number 66. So in summary,
`what do you find about this fifth part of Claim 1, the one that talks about the blind
`hole for the Alto?
`
`A. I find that the Alto has the fifth part of Claim 1.
`
`Id. at 75–76.
`
`Dr. Abraham also testified that the blind holes of the ’911 patent are a type of cavity, one
`
`that you cannot see because they are inside the device and do not “go all the way through the wall.”
`
`Id. at 38 (“Imagine you’ve got a device and instead of looking at it this way, you look at it this
`
`way. You don’t see those cavities because they’re inside. They don’t go all the way through the
`
`wall, so that’s what a blind -- that’s what a cavity being a blind hole means.”); see also id. at 40
`
`(“these are just two different ways that the patent describes these blind hole cavities”). That
`
`testimony accords with the language of claim 1, which discloses that “the at least one cavity is a
`
`blind hole,” ’911 Patent, 18:22, and the prosecution history of the ’911 patent, which shows that
`
`Philip Morris narrowed the application by defining the claimed cavity as a blind hole. See June
`
`10, 2022 (AM) Trial Tr. 20 (“So originally in the patent application, the words ‘blind hole’ were
`
`not in there”); id. at 21 (“So what happened is the patent examiner objected saying that Rose
`
`disclosed cavity, and in Philip Morris’s argument to the Patent Office they defined what defines
`
`“non-blind.”).
`
`The blind hole as described in the ’911 patent is thus a type or subset of cavity, and a
`
`product can only infringe if it contains a cavity that is a blind hole. In this situation, an equivalent
`
`3
`
`
`
`Case 1:20-cv-00393-LMB-TCB Document 1353 Filed 06/14/22 Page 4 of 8 PageID# 33823
`
`to a cavity cannot also be a literal blind hole. Consider the scenario where the jury determines that
`
`the Alto has a cavity only under the doctrine of equivalents. It still has to find that the same Alto
`
`cavity is a blind hole. Because there is no basis in the record for the jury to find that the Alto has
`
`an equivalent to a blind hole, the jury can find infringement only if the Alto has a literal blind hole.
`
`And, the jury cannot find the Alto has a literal blind hole (a subset of cavity) where it has already
`
`found it does not have a literal cavity. The doctrine of equivalents has no role to play in the jury’s
`
`resolution of infringement claim as to the ’911 patent.
`
`If the Court agrees, then the question on doctrine of equivalents for the ’911 patent (Ex. 2,
`
`Section II, Question 2), should be omitted from the verdict form. If both the ’265 and ’911 doctrine
`
`of equivalent questions are omitted from the verdict form, then the Court should omit the
`
`corresponding instruction on doctrine of equivalents. Ex. 1, Instr. No. 21, at 23–24.
`
`II.
`
`APPORTIONMENT
`
`Reynolds objects to the omission of its proposed Final Instruction No. 51 (as filed in Dkt.
`
`1204-1 at 113) (“Reasonable Royalty – Apportionment”). Apportionment remains an issue in this
`
`case because it is part of Philip Morris’s burden to prove damages. The jury need not believe Mr.
`
`McAlexander’s apportionment opinion. See Fuji Photo Film Co. v. Jazz Photo Corp., 394 F.3d
`
`1368, 1378 (Fed. Cir. 2005). Indeed, the jury has heard evidence significantly undercutting that
`
`apportionment opinion. The jury should be permitted to assess Mr. McAlexander’s apportionment
`
`under the law as instructed by the Court. Reynolds therefore preserves its objection as stated
`
`during the charge conference. June 13, 2022 (PM) Trial Tr. at 40:3-13.
`
`III. REYNOLDS’S PROPOSED CHANGES TO PROPOSED FINAL JURY
`INSTRUCTIONS
`
`Reynolds respectfully submits the following edits to the Court’s proposed Jury Instructions
`
`of June 13, 2022 (Exhibit 1):
`
`4
`
`
`
`Case 1:20-cv-00393-LMB-TCB Document 1353 Filed 06/14/22 Page 5 of 8 PageID# 33824
`
`Instruction No. 10: Reynolds suggests that the Court omit “or done” (line 2), “or other
`
`conduct” (line 5), “or other conduct” (line 6), and the entire third paragraph (a single sentence
`
`beginning “An act or omission”) to conform to the Court’s ruling to omit references to inconsistent
`
`conduct. 6/13/22 Tr. 44:23-45:1.
`
`Instruction No. 12: Reynolds requests that the first statement of the issue be revised to
`
`read: “Has Philip Morris proven by a preponderance of the evidence that the VUSE Alto directly
`
`infringes the specified claims of the ’265 Patent and that the VUSE Solo G2 or VUSE Alto directly
`
`infringes the specified claims of the ’911 Patent.” This change reflects that only the VUSE Alto
`
`has been accused of infringing the specified claims of the ’265 Patent.
`
`Reynolds further requests that the Court replace “infringement, validity, and damages”
`
`(lines 14-15) with “infringement and validity,” since licensing and patent ownership are relevant
`
`to the factors listed in Instruction No. 35.
`
`Instruction No. 24: Reynolds requests that the Court replace “that is, you must be left
`
`with a clear conviction that the particular claim is invalid” with “which means that Reynolds must
`
`show that it is highly probable that the claim is invalid,” to conform to the Court’s ruling on
`
`Instruction No. 13. See 6/13/22 Tr. 45:8-11.
`
`Instruction No. 27: Reynolds proposes deleting this instruction, as the parties do not
`
`dispute that the prior art references in this case are printed publications.
`
`Instruction No. 30: Reynolds suggests replacing “asserted patents that Reynolds contends
`
`is obvious” with “’911 Patent.”
`
`
`
`
`
`5
`
`
`
`Case 1:20-cv-00393-LMB-TCB Document 1353 Filed 06/14/22 Page 6 of 8 PageID# 33825
`
`Dated: June 14, 2022
`
`
`
`Stephanie E. Parker
`JONES DAY
`1221 Peachtree Street, N.E.
`Suite 400
`Atlanta, GA 30361
`Telephone: (404) 521-3939
`Facsimile: (404) 581-8330
`Email: separker@jonesday.com
`
`
`Anthony M. Insogna
`JONES DAY
`4655 Executive Drive
`Suite 1500
`San Diego, CA 92121
`Telephone: (858) 314-1200
`Facsimile: (844) 345-3178
`Email: aminsogna@jonesday.com
`
`William E. Devitt
`JONES DAY
`77 West Wacker
`Suite 3500
`Chicago, IL 60601
`Telephone: (312) 269-4240
`Facsimile: (312) 782-8585
`Email: wdevitt@jonesday.com
`
`Sanjiv P. Laud
`JONES DAY
`90 South Seventh Street
`Suite 4950
`Minneapolis, MN 55402
`Telephone: (612) 217-8800
`Facsimile: (844) 345-3178
`Email: slaud@jonesday.com
`
`
`
`
`Respectfully submitted,
`
`
`
`/s/ David M. Maiorana
`
`David M. Maiorana (VA Bar No. 42334)
`Ryan B. McCrum
`JONES DAY
`901 Lakeside Ave.
`Cleveland, OH 44114
`Telephone: (216) 586-3939
`Facsimile: (216) 579-0212
`Email: dmaiorana@jonesday.com
`Email: rbmccrum@jonesday.com
`
`John J. Normile
`JONES DAY
`250 Vesey Street
`New York, NY 10281
`Telephone: (212) 326-3939
`Facsimile: (212) 755-7306
`Email: jjnormile@jonesday.com
`
`
`Alexis A. Smith
`JONES DAY
`555 South Flower Street
`Fiftieth Floor
`Los Angeles, CA 90071
`Telephone: (213) 243-2653
`Facsimile: (213) 243-2539
`Email: asmith@jonesday.com
`
`Charles B. Molster
`THE LAW OFFICES OF
`CHARLES B. MOLSTER, III PLLC
`2141 Wisconsin Avenue, N.W. Suite M
`Washington, DC 20007
`Telephone: (202) 787-1312
`Email: cmolster@molsterlaw.com
`
`Counsel for RAI Strategic Holdings, Inc.
`and R.J. Reynolds Vapor Company
`
`
`
`6
`
`
`
`Case 1:20-cv-00393-LMB-TCB Document 1353 Filed 06/14/22 Page 7 of 8 PageID# 33826
`
`CERTIFICATE OF SERVICE
`
`
`
`I hereby certify that on this 14th day of June, 2022, a true and correct copy of the foregoing
`
`was served using the Court’s CM/ECF system, with electronic notification of such filing to all
`
`counsel of record.
`
`
`
`
`
`
`
`
`
`/s/ David M. Maiorana
`David M. Maiorana (VA Bar No. 42334)
`JONES DAY
`901 Lakeside Ave.
`Cleveland, OH 44114
`Telephone: (216) 586-3939
`Facsimile: (216) 579-0212
`Email: dmaiorana@jonesday.com
`
`Counsel for RAI Strategic Holdings, Inc. and
`R.J. Reynolds Vapor Company
`
`
`
`
`7
`
`
`
`Case 1:20-cv-00393-LMB-TCB Document 1353 Filed 06/14/22 Page 8 of 8 PageID# 33827
`Case 1:20-cv-00393-LMB-TCB Document 1353 Filed 06/14/22 Page 8 of 8 PagelD# 33827
`
`
`
`
`
`
`
`
`-8-
`-8-
`
`
`
`